Meirav Barshimon

Title: Meirav Barshimon: Innovator in Recombinant Protein Expression

Introduction

Meirav Barshimon is a notable inventor based in Gedera, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of methods for expressing recombinant proteins. His innovative approach has the potential to enhance the efficiency of protein production in various applications.

Latest Patents

Barshimon holds a patent for "Low fucose cell lines and uses thereof." This patent describes a method for selecting cells with zero fucose levels, which are useful as host cells for expressing recombinant proteins. The method involves introducing genetic mutations into a population of CHO cells and utilizing a non-toxic fucose binding agent to select cells that do not bind to fucose. This innovative technique allows for the identification of cells that can effectively produce recombinant proteins without the interference of fucose.

Career Highlights

Meirav Barshimon is currently employed at Merck Serono S.A., where he continues to advance his research in biotechnology. His work focuses on improving the production processes for recombinant proteins, which are essential in therapeutic applications. Barshimon's expertise and innovative methods have positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Barshimon has collaborated with several talented individuals, including Daniel Helman and Mira Toister-Achituv. These collaborations have fostered a dynamic research environment, leading to advancements in the field of recombinant protein expression.

Conclusion

Meirav Barshimon's contributions to biotechnology, particularly in the area of recombinant protein expression, highlight his innovative spirit and dedication to advancing scientific knowledge. His patent and ongoing work at Merck Serono S.A. demonstrate the impact of his research on the industry.